Kura Oncology Logo

Kura Oncology

Precision cancer treatment

Oncology
Precision Medicine
Targeted Therapeutics
Biomarkers
Solid Tumors

About Kura Oncology

Kura Oncology is a clinical-stage biopharmaceutical company focused on precision medicines for cancer treatment. Our small-molecule drug candidates target key cancer drivers to improve patient outcomes. Kura’s pipeline includes ziftomenib, tipifarnib, and KO-2806, each in various trial phases. We offer career opportunities in roles such as Senior Director, Legal Counsel, and Quality Assurance. Join us in our mission to advance cancer treatment.

Overview

  • Website
  • LinkedIn
  • 51-200 employees
  • Founded in 2014
  • 7 active jobs
  • Hiring in:
    • Worldwide
    • 🇺🇸 United States